Prolonged allogeneic islet graft survival by protoporphyrins

Antonello Pileggi, Ruth Molano, Thierry Berney, Hirohito Ichii, Sergio San Jose, Elsie Zahr, Raffaella Poggioli, Elina Linetsky, Camillo Ricordi, Luca A Inverardi

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Transplantation of islets of Langerhans in patients with type 1 diabetes allows for improved metabolic control and insulin independence. The need for chronic immunosuppression limits this procedure to selected patients with brittle diabetes. Definition of therapeutic strategies allowing permanent engraftment without the need for chronic immunosuppression could overcome such limitations. We tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein heme-oxygenase I (HO-1), on allogeneic islet graft survival. Chemically induced diabetic C57BL/6 mice received DBA/2 islets. Treatment consisted in peritransplant administration of CoPP or saline. Islets were either cultured in the presence of FePP or vehicle before implant. Short-course administration of CoPP led to long-term islet allograft survival in a sizable proportion of recipients. Long-term graft-bearing animals rejected third-party islets while accepting a second set donor-specific graft permanently, without additional treatment. Preconditioning of islets with FePP by itself led to improved graft survival in untreated recipients, and provided additional advantage in CoPP-treated recipients, resulting in an increased proportion of long-term surviving grafts. Preconditioning of the graft with protoporphyrins prior to implant resulted in reduction of class II expression. Administration of protoporphyrins to the recipients of allogeneic islets also resulted in transient powerful immunosuppression with reduced lymphocyte proliferative responses, increased proportion of regulatory cells (CD4+CD25+), decreased mononuclear cell infiltrating the graft, paralleled by a systemic upregulation of HO-1 expression. All these mechanisms may have contributed to the induction of donor-specific hyporesponsiveness in a proportion of the protoporphyrin- treated animals.

Original languageEnglish
Pages (from-to)85-96
Number of pages12
JournalCell Transplantation
Volume14
Issue number2-3
StatePublished - May 13 2005

Fingerprint

Protoporphyrins
Graft Survival
Grafts
Transplants
Immunosuppression
Medical problems
Tissue Donors
Heme Oxygenase (Decyclizing)
Islets of Langerhans Transplantation
Animals
Bearings (structural)
Type 1 Diabetes Mellitus
Inbred C57BL Mouse
Transplantation (surgical)
Allografts
Lymphocytes
Insulin
Up-Regulation
Therapeutics
Proteins

Keywords

  • Allograft survival
  • Cobalt protoporphyrin (CoPP)
  • Diabetes
  • Heme oxygenase-1 (HO-1)
  • Iron protoporphyrin (FePP, hemin)
  • Islet transplantation
  • MHC class II
  • Tolerance

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Pileggi, A., Molano, R., Berney, T., Ichii, H., San Jose, S., Zahr, E., ... Inverardi, L. A. (2005). Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplantation, 14(2-3), 85-96.

Prolonged allogeneic islet graft survival by protoporphyrins. / Pileggi, Antonello; Molano, Ruth; Berney, Thierry; Ichii, Hirohito; San Jose, Sergio; Zahr, Elsie; Poggioli, Raffaella; Linetsky, Elina; Ricordi, Camillo; Inverardi, Luca A.

In: Cell Transplantation, Vol. 14, No. 2-3, 13.05.2005, p. 85-96.

Research output: Contribution to journalArticle

Pileggi, A, Molano, R, Berney, T, Ichii, H, San Jose, S, Zahr, E, Poggioli, R, Linetsky, E, Ricordi, C & Inverardi, LA 2005, 'Prolonged allogeneic islet graft survival by protoporphyrins', Cell Transplantation, vol. 14, no. 2-3, pp. 85-96.
Pileggi A, Molano R, Berney T, Ichii H, San Jose S, Zahr E et al. Prolonged allogeneic islet graft survival by protoporphyrins. Cell Transplantation. 2005 May 13;14(2-3):85-96.
Pileggi, Antonello ; Molano, Ruth ; Berney, Thierry ; Ichii, Hirohito ; San Jose, Sergio ; Zahr, Elsie ; Poggioli, Raffaella ; Linetsky, Elina ; Ricordi, Camillo ; Inverardi, Luca A. / Prolonged allogeneic islet graft survival by protoporphyrins. In: Cell Transplantation. 2005 ; Vol. 14, No. 2-3. pp. 85-96.
@article{9e5a073f220e4b9b9f65106c48a60b49,
title = "Prolonged allogeneic islet graft survival by protoporphyrins",
abstract = "Transplantation of islets of Langerhans in patients with type 1 diabetes allows for improved metabolic control and insulin independence. The need for chronic immunosuppression limits this procedure to selected patients with brittle diabetes. Definition of therapeutic strategies allowing permanent engraftment without the need for chronic immunosuppression could overcome such limitations. We tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein heme-oxygenase I (HO-1), on allogeneic islet graft survival. Chemically induced diabetic C57BL/6 mice received DBA/2 islets. Treatment consisted in peritransplant administration of CoPP or saline. Islets were either cultured in the presence of FePP or vehicle before implant. Short-course administration of CoPP led to long-term islet allograft survival in a sizable proportion of recipients. Long-term graft-bearing animals rejected third-party islets while accepting a second set donor-specific graft permanently, without additional treatment. Preconditioning of islets with FePP by itself led to improved graft survival in untreated recipients, and provided additional advantage in CoPP-treated recipients, resulting in an increased proportion of long-term surviving grafts. Preconditioning of the graft with protoporphyrins prior to implant resulted in reduction of class II expression. Administration of protoporphyrins to the recipients of allogeneic islets also resulted in transient powerful immunosuppression with reduced lymphocyte proliferative responses, increased proportion of regulatory cells (CD4+CD25+), decreased mononuclear cell infiltrating the graft, paralleled by a systemic upregulation of HO-1 expression. All these mechanisms may have contributed to the induction of donor-specific hyporesponsiveness in a proportion of the protoporphyrin- treated animals.",
keywords = "Allograft survival, Cobalt protoporphyrin (CoPP), Diabetes, Heme oxygenase-1 (HO-1), Iron protoporphyrin (FePP, hemin), Islet transplantation, MHC class II, Tolerance",
author = "Antonello Pileggi and Ruth Molano and Thierry Berney and Hirohito Ichii and {San Jose}, Sergio and Elsie Zahr and Raffaella Poggioli and Elina Linetsky and Camillo Ricordi and Inverardi, {Luca A}",
year = "2005",
month = "5",
day = "13",
language = "English",
volume = "14",
pages = "85--96",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "2-3",

}

TY - JOUR

T1 - Prolonged allogeneic islet graft survival by protoporphyrins

AU - Pileggi, Antonello

AU - Molano, Ruth

AU - Berney, Thierry

AU - Ichii, Hirohito

AU - San Jose, Sergio

AU - Zahr, Elsie

AU - Poggioli, Raffaella

AU - Linetsky, Elina

AU - Ricordi, Camillo

AU - Inverardi, Luca A

PY - 2005/5/13

Y1 - 2005/5/13

N2 - Transplantation of islets of Langerhans in patients with type 1 diabetes allows for improved metabolic control and insulin independence. The need for chronic immunosuppression limits this procedure to selected patients with brittle diabetes. Definition of therapeutic strategies allowing permanent engraftment without the need for chronic immunosuppression could overcome such limitations. We tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein heme-oxygenase I (HO-1), on allogeneic islet graft survival. Chemically induced diabetic C57BL/6 mice received DBA/2 islets. Treatment consisted in peritransplant administration of CoPP or saline. Islets were either cultured in the presence of FePP or vehicle before implant. Short-course administration of CoPP led to long-term islet allograft survival in a sizable proportion of recipients. Long-term graft-bearing animals rejected third-party islets while accepting a second set donor-specific graft permanently, without additional treatment. Preconditioning of islets with FePP by itself led to improved graft survival in untreated recipients, and provided additional advantage in CoPP-treated recipients, resulting in an increased proportion of long-term surviving grafts. Preconditioning of the graft with protoporphyrins prior to implant resulted in reduction of class II expression. Administration of protoporphyrins to the recipients of allogeneic islets also resulted in transient powerful immunosuppression with reduced lymphocyte proliferative responses, increased proportion of regulatory cells (CD4+CD25+), decreased mononuclear cell infiltrating the graft, paralleled by a systemic upregulation of HO-1 expression. All these mechanisms may have contributed to the induction of donor-specific hyporesponsiveness in a proportion of the protoporphyrin- treated animals.

AB - Transplantation of islets of Langerhans in patients with type 1 diabetes allows for improved metabolic control and insulin independence. The need for chronic immunosuppression limits this procedure to selected patients with brittle diabetes. Definition of therapeutic strategies allowing permanent engraftment without the need for chronic immunosuppression could overcome such limitations. We tested the effect of the use of protoporphyrins (CoPP and FePP), powerful inducers of the cytoprotective protein heme-oxygenase I (HO-1), on allogeneic islet graft survival. Chemically induced diabetic C57BL/6 mice received DBA/2 islets. Treatment consisted in peritransplant administration of CoPP or saline. Islets were either cultured in the presence of FePP or vehicle before implant. Short-course administration of CoPP led to long-term islet allograft survival in a sizable proportion of recipients. Long-term graft-bearing animals rejected third-party islets while accepting a second set donor-specific graft permanently, without additional treatment. Preconditioning of islets with FePP by itself led to improved graft survival in untreated recipients, and provided additional advantage in CoPP-treated recipients, resulting in an increased proportion of long-term surviving grafts. Preconditioning of the graft with protoporphyrins prior to implant resulted in reduction of class II expression. Administration of protoporphyrins to the recipients of allogeneic islets also resulted in transient powerful immunosuppression with reduced lymphocyte proliferative responses, increased proportion of regulatory cells (CD4+CD25+), decreased mononuclear cell infiltrating the graft, paralleled by a systemic upregulation of HO-1 expression. All these mechanisms may have contributed to the induction of donor-specific hyporesponsiveness in a proportion of the protoporphyrin- treated animals.

KW - Allograft survival

KW - Cobalt protoporphyrin (CoPP)

KW - Diabetes

KW - Heme oxygenase-1 (HO-1)

KW - Iron protoporphyrin (FePP, hemin)

KW - Islet transplantation

KW - MHC class II

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=20944432464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944432464&partnerID=8YFLogxK

M3 - Article

C2 - 15881418

AN - SCOPUS:20944432464

VL - 14

SP - 85

EP - 96

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 2-3

ER -